Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce one of the Journal's Section Editors for this issue.
Ellen W. Seely is Director of Clinical Research for the Endocrinology, Diabetes and Hypertension Division at Brigham and Women's Hospital, USA. She is also Professor of Medicine at Harvard Medical School, USA. Dr Seely received her MD from Columbia University College of Physicians and Surgeons, USA and her training in Internal Medicine and Endocrinology and Metabolism at Brigham and Women's Hospital. Dr Seely directs the Unique Cardiovascular Risk Factors in Women Research and Mentoring Program, at Brigham and Women's Hospital which is supported by a NIH K24 Award. She serves as Vice Chair of Faculty Development in the Department of Medicine at Brigham and Women's Hospital and as Past-President of the Association for Patient Oriented Research.
David Handelsman is Professor of Reproductive Endocrinology and Andrology, at the University of Sydney, Australia, and inaugural Director of the ANZAC Research Institute and head of Andrology Department, Concord Hospital, Australia. His interests in Andrology (male reproductive health, medicine and biology) involve basic, clinical, translation and public health research centred on the physiology, pharmacology and toxicology of androgens. Recent research has focused on genetic mouse models of tissue-specific androgen action in testis, prostate, breast and ovary notably hormonal regulation of spermatogenesis, detection of androgen doping in sport, steroid mass spectrometry and clinical pharmacology and trials of androgens in androgen deficiency, hormonal male contraception, male ageing and prostate disease.